retatrutide approved by fda Letter regarding Retatrutide FDA Approval Status 2026:

It binds to bone morphogenetic proteins and negatively affects bone formation by inhibiting ALP activity, type I collagen synthesis, and mineralization (45)

The GLP-1 component suppresses appetite and improves insulin secretion

Retratrudide will be a prescription-only medication, meaning it will not be available for purchase over the counter once it is released

Endocr Practice: Official J Am Coll Endoc Rinology Am Association Clin Endocrinologists, 22 Suppl 3:1203

In fact, it can cause disordered eating patterns in people who take it

Common myths about GLP-1 injection timing Misinformation about injection timing circulates widely on social media and forums